Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Antineoplastic And Endocrinological Agents (L01-L02)

Aktsiaselts Ida-Tallinna Keskhaigla Estonia has Released a tender for Antineoplastic And Endocrinological Agents (L01-L02) in Pharmaceuticals. The tender was released on Jan 20, 2025.

Country - Estonia

Summary - Antineoplastic And Endocrinological Agents (L01-L02)

Deadline - Feb 17, 2025

GT reference number - 101821681

Product classification - Pharmaceutical products

Organization Details:

  Address - Estonia

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 101821681

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Purchase of medicines as described in RHAD Annex I Technical Specification-Tender Form.local title:: Kasvajavastased ja endokrinoloogilised ained (L01-L02)Contract Type: : Supplylocal description: : Ravimite ostmine vastavalt RHAD lisas I Tehniline kirjeldus-pakkumuse vorm kirjeldatule.Net Budget Euro: : 12398000.0Net Budget LC: : 12398000.0 dispatch_date: 2025-01-16 00:00:00 est_amount: 12398000.0 lot_details: 1: Cyclophosphamide, 2: Ifosfamide, 3: Temosolomiid, 4: Methotrexate, 5: Pemetrekseed, 6: Fluorouratsiil, 7: Gemcitabine, 8: Capecitabine, 9: Vinorelbine, 10: Etoposide, concentrate for solution for infusion, 100mg-200mg per vial, 11: Etoposide, soft capsule, 100mg, 12: P

Gt Ref Id - 101821681

Deadline - Feb 17, 2025

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database